Interesting facts
Interesting Facts About (2R,3R,6S)-3-[[(3S)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxo-pyrimidin-1-yl)-3,6-dihydro-2H-pyran-2-carboxylic acid
This compound, a notable entity in the realm of biochemistry, is primarily recognized for its role as a potential pharmacological agent. Here are some fascinating aspects:
- Structural Complexity: The compound possesses an intricate structure that involves multiple elements such as amino acids and pyrimidine derivatives, highlighting the sophistication of natural product chemistry.
- Biological Significance: Its various components, particularly the amino acids, play crucial roles in biochemical processes within living organisms, including protein synthesis and metabolic pathways.
- Pharmaceutical Potential: Researchers are exploring this compound in relation to its possible effectiveness in treating specific diseases, making it a subject of interest in drug development.
- Chirality: The stereochemistry, indicated by the (2R,3R,6S) configuration, adds to its complexity and can significantly influence its biological interactions, showcasing the importance of chirality in medicinal chemistry.
- Interdisciplinary Applications: This compound serves as a bridge between organic chemistry, pharmacology, and medicinal chemistry, demonstrating the interconnectedness of scientific disciplines in the quest for new therapies.
In the words of renowned chemist Linus Pauling, "The best way to have a good idea is to have a lot of ideas." This compound exemplifies this philosophy, as it opens up numerous avenues for research and discovery within the scientific community. Its synthesis and the exploration of its properties continue to provide insight into the fascinating world of molecular interactions and therapeutic strategies.
Synonyms
Blasticidin S
Bla-S
Blastizidin
TOA bla-S
Blastizidin [German]
blasticidin-S
HSDB 6569
83U64J9U23
BLASTICIDIN S [MI]
BLASTICIDIN-S [HSDB]
1-(1'-Cytosinyl)-4-(L-3'-amino-5'-(1''-N-methylguanidino)valerylamino)-1,2,3,4-tetradeoxy-beta-D-erythro-hex-2-enuronic acid
CYTOSININE-BLASTIDIC ACID CONJUGATE
beta-D-erythro-Hex-2-enopyranuronic acid, 4-((3-amino-5-((aminoiminomethyl)methylamino)-1-oxopentyl)amino)-1-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,2,3,4-tetradeoxy-, (S)-
D-erythro-Hex-2-enopyranuronic acid, 4-(3-amino-5-(1-methylguanidino)valeramido)-1-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,2,3,4-tetradeoxy-
2079-00-7
(s)-4-((3-Amino-5-((aminoiminomethyl)methylamino)-1-oxopentyl)amino)-1-(4-amino-2-oxo-1(2h)-pyrimidin yl)-1,2,3,4-tetradeoxy-b-d-erythro-hex-2-enopyranuronic acid
1-(1'-Cytosinyl)-4-(l-3'-amino-5'-(1"-n-methylguanidino)valerylamino)-12,3,4-tetradeoxy-beta-d-erythro-hex-2-enuronic acid
1-(1'-CYTOSINYL)-4-(L-3'-AMINO-5'-(1''-N-METHYLGUANIDINO)-VALERYLAMINO)-1,2,3,4-TETRADEOXY-.BETA.-D-ERYTHRO-HEX-2-ENURONIC ACID
1-(4-Amino-1,2-dihydro-2-oxopyrimidin-1-yl)-4-((s)-3-amino-5-(1-methyl-guanidino)valeramido)-1,2,3,4-tetradeoxy-beta-d-erythro-hex-2-enopyra-nuronic acid
DTXSID0058015
TOA blaS
(S)-4-4((3-amino-5-((aminoiminomethyl)methylamino)-=1-oxopentyl)amino)-1-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,2,3,4-tetradeoxy-beta-D-erythro-hex-=2-enopyranuronic acid
(S)-4-4[[3-amino-5-[(aminoiminomethyl)methylamino]-=1-oxopentyl]amino]-1-[4-amino-2-oxo-1(2H)-pyrimidinyl]-1,2,3,4-tetradeoxy-beta-D-erythro-hex-=2-enopyranuronic acid
1-(4-amino-1,2-dihydro-2-oxopyrimidin-1-yl)-4-((S)-3-amino-=5-(1-methylguanidino)valeramido)-1,2,3,4-tetradeoxy-beta-D-erythro-hex-2-enopyranuronic acid
1-(4-amino-1,2-dihydro-2-oxopyrimidin-1-yl)-4-[(S)-3-amino-=5-(1-methylguanidino)valeramido]-1,2,3,4-tetradeoxy-beta-D-erythro-hex-2-enopyranuronic acid
1-(4-amino-1,2-dihydro-2-oxopyrimidin-1-yl)-4-{(S)-3-amino-5-(1-methyl-guanidino)valeramido]-1,2,3,4-tetradeoxy-beta-D-erythro-hex-2-enopyra-nuronic acid
BLASTICIDIN_S
DTXCID3031783
(2S,3S,6R)-3-(3-amino-5-(N-methylcarbamimidamido)pentanamido)-6-(4-amino-2-oxo-2H-pyrimidin-1-yl)-3,6-dihydro-2H-pyran-2-carboxylic acid
(2S,3S,6R)-3-[3-amino-5-(N-methylcarbamimidamido)pentanamido]-6-(4-amino-2-oxo-2H-pyrimidin-1-yl)-3,6-dihydro-2H-pyran-2-carboxylic acid
4-amino-1-(4-(((3S)-3-amino-5-(N-methylcarbamimidamido)pentanoyl)amino)-2,3,4-trideoxy-beta-D-erythro-hex-2-enopyranuronosyl)pyrimidin-2(1H)-one
4-amino-1-(4-{[(3S)-3-amino-5-(N-methylcarbamimidamido)pentanoyl]amino}-2,3,4-trideoxy-beta-D-erythro-hex-2-enopyranuronosyl)pyrimidin-2(1H)-one
UN3172
.beta.-D-erythro-Hex-2-enopyranuronic acid, 4-[[3-amino-5-[(aminoiminomethyl)methylamino]-1-oxopentyl]amino]-1-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,2,3,4-tetradeoxy-, (S)-
1(1'Cytosinyl)4(L3'amino5'(1''Nmethylguanidino)valerylamino)1,2,3,4tetradeoxybetaDerythrohex2enuronic acid
1-(1'-CYTOSINYL)-4-(L-3'-AMINO-5'-(1''-N-METHYLGUANIDINO)-VALERYLAMINO)-1,2,3,4-TETRADEOXY-BETA-D-ERYTHRO-HEX-2-ENURONIC ACID
606-640-2
betaDerythroHex2enopyranuronic acid, 4((3amino5((aminoiminomethyl)methylamino)1oxopentyl)amino)1(4amino2oxo1(2H)pyrimidinyl)1,2,3,4tetradeoxy, (S)
D-erythro-Hex-2-enopyranuronic acid, 4-(3-amino-5-(1-methylguanidino)valeramido)-1-(4-amino-2-oxo-1 (2H0-PYRIMIDINYL)-1,2,3,4-tetradeoxy-
DerythroHex2enopyranuronic acid, 4(3amino5(1methylguanidino)valeramido)1(4amino2oxo1(2H)pyrimidinyl)1,2,3,4tetradeoxy
(2s,3s,6r)-3-(((3s)-3-amino-5-(carbamimidoyl(methyl)amino)pentanoyl)amino)-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid
(2s,3s,6r)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid
CYTOVIRIN
UNII-83U64J9U23
CHEMBL511116
SCHEMBL15263240
Solubility of (2R,3R,6S)-3-[[[3S)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxo-pyrimidin-1-yl)-3,6-dihydro-2H-pyran-2-carboxylic acid
The solubility of this compound can be characterized by several key factors that influence how it behaves in various solvents. Understanding its solubility is essential for applications in pharmaceuticals and biochemical research.
It is important to note that while its polar functional groups contribute to increasing solubility in aqueous environments, there may still be challenges in dissolving this compound in non-polar solvents due to its complex structure. Further investigation through empirical testing is often necessary to establish definitive solubility profiles.